Results 11 to 20 of about 68 (53)

Delayed negative effects of prosocial spending on happiness. [PDF]

Proc Natl Acad Sci U S A, 2020
Falk A, Graeber T.
europepmc   +1 more source

Africa's cellular solution to TB. [PDF]

CMAJ, 2013
Appiah B.
europepmc   +1 more source

AIDS-related mycoses: the way forward. [PDF]

Trends Microbiol, 2014
Brown GD, Meintjes G, Kolls JK, Gray C, Horsnell W, Working Group from the EMBO-AIDS Related Mycoses Workshop, Achan B, Alber G, Aloisi M, Armstrong-James D, Beale M, Bicanic T, Black J, Bohjanen P, Botes A, Boulware DR, Brown G, Bunjun R, Carr W, Casadevall A, Chang C, Chivero E, Corcoran C, Cross A, Dawood H, Day J, De Bernardis F, De Jager V, De Repentigny L, Denning D, Eschke M, Finkelman M, Govender N, Gow N, Graham L, Gryschek R, Hammond-Aryee K, Harrison T, Heard N, Hill M, Hoving JC, Janoff E, Jarvis J, Kayuni S, King K, Kolls J, Kullberg BJ, Lalloo DG, Letang E, Levitz S, Limper A, Longley N, Machiridza TR, Mahabeer Y, Martinsons N, Meiring S, Meya D, Miller R, Molloy S, Morris L, Mukaremera L, Musubire AK, Muzoora C, Nair A, Nakiwala Kimbowa J, Netea M, Nielsen K, O'hern J, Okurut S, Parker A, Patterson T, Pennap G, Perfect J, Prinsloo C, Rhein J, Rolfes MA, Samuel C, Schutz C, Scriven J, Sebolai OM, Sojane K, Sriruttan C, Stead D, Steyn A, Thawer NK, Thienemann F, Von Hohenberg M, Vreulink JM, Wessels J, Wood K, Yang YL.   +90 more
europepmc   +1 more source

Back to the future: a new 'old' lead for tuberculosis. [PDF]

EMBO Mol Med, 2012
Wright GD.
europepmc   +1 more source

Incidence rates and deaths of tuberculosis in HIV-negative patients in the United States and Germany as analyzed by new predictive model for infection. [PDF]

PLoS One, 2012
Ren Y, Ding F, Suo S, Bu RE, Zarlenga DS, Ren X.   +5 more
europepmc   +1 more source

Novel polymorphisms in TICAM2 and NOD1 associated with tuberculosis progression phenotypes in Ethiopian populations. [PDF]

Glob Health Epidemiol Genom, 2018
Mekonnen E, Bekele E, Stein CM.
europepmc   +1 more source

Pharmacogenetic association between NAT2 gene polymorphisms and isoniazid induced hepatotoxicity: trial sequence meta-analysis as evidence. [PDF]

Biosci Rep, 2019
Khan S, Mandal RK, Elasbali AM, Dar SA, Jawed A, Wahid M, Mahto H, Lohani M, Mishra BN, Akhter N, Rabaan AA, Haque S.   +11 more
europepmc   +1 more source

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy. [PDF]

Oncoimmunology, 2012
Vacchelli E, Galluzzi L, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G.   +8 more
europepmc   +1 more source

Extrahepatic biliary tract tuberculosis: A case report and literature review. [PDF]

Int J Surg Case Rep
Pham AT, Dang QH, Dang KK, Nguyen ATM, Truong CM, Nguyen KT.   +5 more
europepmc   +1 more source

Use of microelectronic array technology for rapid identification of clinically relevant mycobacteria. [PDF]

J Clin Microbiol, 2005
Sanguinetti M, Novarese L, Posteraro B, Ranno S, De Carolis E, Pecorini G, Lucignano B, Ardito F, Fadda G.   +8 more
europepmc   +1 more source